Ironwood Pharmaceuticals, Inc. (IRWD)
4.06
+0.08
(+2.01%)
USD |
NASDAQ |
Jan 09, 16:00
4.11
+0.05
(+1.23%)
After-Hours: 20:00
Ironwood Pharmaceuticals Research and Development Expense (Quarterly): 21.99M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AbbVie, Inc. | 2.319B |
| Outlook Therapeutics, Inc. | 7.135M |
| Plus Therapeutics, Inc. | 2.436M |
| Nektar Therapeutics | 27.25M |
| Rigel Pharmaceuticals, Inc. | 7.353M |